RenaissanceRe (NYSE: RNR) director receives 578-share restricted stock grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Klehm Henry III reported acquisition or exercise transactions in this Form 4 filing.
RenaissanceRe Holdings Ltd director Henry Klehm III received a grant of 578 shares of common stock as a restricted stock award. The award was made at a price of $0.00 per share under the company’s long term incentive plan and is structured as equity compensation rather than a cash payment.
The restricted shares will vest in three equal annual installments beginning on March 1, 2027, meaning the director gains full ownership over time if service-based conditions are met. After this grant, he holds 20,305 common shares directly, and a further 13 shares are held indirectly through his spouse’s IRA account.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Klehm Henry III
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 578 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 20,305 shares (Direct);
Common Stock — 13 shares (Indirect, by Spouse)
Footnotes (1)
- Grant of restricted shares of the issuer pursuant to the RenaissanceRe Holdings Ltd. First Amended and Restated 2016 Long Term Incentive Plan, as amended. These shares will vest in three equal annual installments beginning on March 1, 2027. These securities are held by the spouse of the Reporting Person in an IRA account.
FAQ
What insider transaction did RNR director Henry Klehm III report on this Form 4?
RNR director Henry Klehm III reported receiving a grant of 578 shares of common stock. These are restricted shares issued as equity compensation, not an open-market purchase, increasing his directly held stake under the company’s long term incentive plan.
Is this RNR Form 4 transaction a market buy or a compensation grant?
This Form 4 reports a compensation grant, not a market purchase. The 578 shares were awarded as restricted stock at $0.00 per share under the company’s long term incentive plan, representing equity-based pay rather than an open-market buy or sell trade.